Patents by Inventor Youjin NA

Youjin NA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11754557
    Abstract: Disclosed are a method for analyzing an activation state of a signaling pathway in a cell or tissue through protein-protein interaction analysis, a method for selecting a tailored personal therapeutic agent and/or monitoring efficacy of a therapeutic agent using the analysis method, and a device for use therein.
    Type: Grant
    Filed: April 19, 2018
    Date of Patent: September 12, 2023
    Assignee: PROTEINA, INC.
    Inventors: Hong Won Lee, Youjin Na
  • Patent number: 11235072
    Abstract: The present invention relates to an adenovirus complex which can be utilized for gene delivery and gene therapy by targeting neurotensin receptors. The complex of the present invention has an excellent antitumor effect because of a high intracellular gene transfer efficiency and target specificity by neurotensin receptor-specific binding, has little hepatotoxicity and immunogenicity, forms a stable complex, has low immunogenicity, and thus has a low loss in blood even in an in vivo environment. Therefore, the complex of the present invention can be effectively used for gene therapy.
    Type: Grant
    Filed: April 12, 2018
    Date of Patent: February 1, 2022
    Inventors: Chae Ok Yun, Youjin Na
  • Publication number: 20200386747
    Abstract: Disclosed are a method for analyzing an activation state of a signaling pathway in a cell or tissue through protein-protein interaction analysis, a method for selecting a tailored personal therapeutic agent and/or monitoring efficacy of a therapeutic agent using the analysis method, and a device for use therein.
    Type: Application
    Filed: April 19, 2018
    Publication date: December 10, 2020
    Inventors: Hong Won LEE, Youjin NA
  • Publication number: 20180296701
    Abstract: The present invention relates to an adenovirus complex which can be utilized for gene delivery and gene therapy by targeting neurotensin receptors. The complex of the present invention has an excellent antitumor effect because of a high intracellular gene transfer efficiency and target specificity by neurotensin receptor-specific binding, has little hepatotoxicity and immunogenicity, forms a stable complex, has low immunogenicity, and thus has a low loss in blood even in an in vivo environment. Therefore, the complex of the present invention can be effectively used for gene therapy.
    Type: Application
    Filed: April 12, 2018
    Publication date: October 18, 2018
    Inventors: Chae Ok YUN, Youjin NA